Richard Pzena’s T-Mobile US TMUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-975
Closed -$205K 168
2026
Q1
$205K Buy
+975
New +$200K ﹤0.01% 158
2024
Q4
Sell
-1,845
Closed -$381K 163
2024
Q3
$381K Sell
1,845
-907
-33% -$174K ﹤0.01% 146
2024
Q2
$485K Sell
2,752
-107
-4% -$17.9K ﹤0.01% 144
2024
Q1
$467K Sell
2,859
-293
-9% -$47.7K ﹤0.01% 146
2023
Q4
$505K Sell
3,152
-86
-3% -$12.7K ﹤0.01% 146
2023
Q3
$453K Hold
3,238
﹤0.01% 145
2023
Q2
$450K Sell
3,238
-280
-8% -$39.3K ﹤0.01% 148
2023
Q1
$510K Sell
3,518
-2,367
-40% -$343K ﹤0.01% 145
2022
Q4
$824K Buy
+5,885
New +$846K ﹤0.01% 141
2022
Q1
Sell
-3,983
Closed -$462K 184
2021
Q4
$462K Sell
3,983
-348
-8% -$41K ﹤0.01% 157
2021
Q3
$553K Buy
4,331
+103
+2% +$14.3K ﹤0.01% 148
2021
Q2
$612K Sell
4,228
-1,311
-24% -$181K ﹤0.01% 140
2021
Q1
$694K Buy
+5,539
New +$698K ﹤0.01% 144
2014
Q2
Sell
-17,600
Closed -$581K 149
2014
Q1
$581K Sell
17,600
-1,033,250
-98% -$32.8M ﹤0.01% 142
2013
Q4
$35.4M Sell
1,050,850
-7,350
-0.7% -$201K 0.21% 78
2013
Q3
$27.5M Buy
1,058,200
+24,950
+2% +$610K 0.18% 88
2013
Q2
$25.6M Buy
+1,033,250
New +$22.1M 0.17% 89

Other funds holding TMUS

Richard Pzena's TMUS Position: Q2 2026 in Review

Richard Pzena sold out of T-Mobile US (TMUS) in Q2 2026, closing a stake of 975 shares — an estimated $205K sold.

Richard Pzena first reported a position in TMUS in Q2 2013 and held it in 17 quarters. The position peaked at $35.4M in Q4 2013. 1,650 funds tracked by Wall St. Rank hold TMUS as of Q2 2026.

  • Richard Pzena reported no remaining T-Mobile US position as of Q2 2026 after selling out during the quarter.
  • Richard Pzena sold 975 T-Mobile US shares in Q2 2026, an estimated $205K.
  • Richard Pzena first reported a position in T-Mobile US in Q2 2013 and held it in 17 quarters.
  • Richard Pzena's T-Mobile US position peaked at $35.4M in Q4 2013.
  • 1,650 funds tracked by Wall St. Rank held T-Mobile US as of Q2 2026.

Based on Pzena Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.